Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-1803
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice ; volume:117 ; number:1 ; day:28 ; month:2 ; year:2022 ; pages:1-2 ; date:12.2022
Basic research in cardiology ; 117, Heft 1 (28.2.2022), 1-2, 12.2022
- Urheber
-
Werner, Franziska
Kojonazarov, Baktybek
Gaßner, Birgit
Abeßer, Marco
Schuh, Kai
Völker, Katharina
Baba, Hideo A.
Dahal, Bhola K.
Schermuly, Ralph T.
Kuhn, Michaela
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00395-022-00916-9
- URN
-
urn:nbn:de:101:1-2022052823092007101049
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Werner, Franziska
- Kojonazarov, Baktybek
- Gaßner, Birgit
- Abeßer, Marco
- Schuh, Kai
- Völker, Katharina
- Baba, Hideo A.
- Dahal, Bhola K.
- Schermuly, Ralph T.
- Kuhn, Michaela
- SpringerLink (Online service)
Ähnliche Objekte (12)
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Regulation of atrial natriuretic peptide (ANP) secretion
Awareness of atrial fibrogenesis and natriuretic peptide release
Natriuretic peptides for the detection of paroxysmal atrial fibrillation
Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis
Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Regulation of atrial natriuretic peptide (ANP) secretion
Awareness of atrial fibrogenesis and natriuretic peptide release
Natriuretic peptides for the detection of paroxysmal atrial fibrillation
Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis
Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice
Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Endothelial barrier protection by natural compounds : crataegus extract WS 1442 and atrial natriuretic peptide inhibit endothelial hyperpermeability
Regulation of atrial natriuretic peptide (ANP) secretion
Awareness of atrial fibrogenesis and natriuretic peptide release
Natriuretic peptides for the detection of paroxysmal atrial fibrillation
Targeting myocardial inflammation: investigating the therapeutic potential of atrial natriuretic peptide in atrial fibrosis
Atrial natriuretic peptide and three-dimensional echocardiography after transcatheter closure of atrial septal defect
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics